Serrapeptase: The “Miracle Enzyme” for Recovery and Tissue Support

Introduction

Serrapeptase is one of the most popular systemic enzymes used in nutritional practice. Unlike digestive enzymes that are primarily used to break down food, serrapeptase is taken between meals so it can be absorbed and distributed throughout the body. This enzyme is produced through fermentation and has been studied for its effects on recovery, tissue health, circulation, and respiratory wellness.¹

Serrapeptase is a “Proteolytic Enzyme”

Serrapeptase acts as a proteolytic enzyme to break larger proteins into smaller fragments. When taken with meals, serrapeptase can assist digestion. When taken away from food, serrapeptase can be absorbed intact and interact with physiological processes beyond the digestive tract to exert a systemic effect.

In research conducted in Europe and Japan in the 1980s and 1990s, serrapeptase was identified as the most effective systemic proteolytic enzyme in promoting health benefits.² The legendary Dr. Hans Nieper, a German medical physician renowned for his extensive knowledge of proteolytic enzymes, called serrapeptase the "Miracle Enzyme."³

The Serrapeptase Discovery

One of the most interesting aspects of serrapeptase is its discovery. The enzyme was originally identified in Japan in 1970 from Serratia marcescens, a bacteria that lives within the digestive tract of silkworms. The developed moth uses serrapeptase to dissolve its cocoon and emerge fully formed. The proteolytic action of the enzyme impressively breakdowns the cocoon’s strong structural proteins. This powerful effect was one the key serrapeptase attracted interest as a supplemental proteolytic enzyme.¹

Modern production of serrapeptase is involves controlled fermentation processes using cultures of Serratia marcescens. It may also appear on product labels under alternative names such as serratiopeptidase, serrapeptidase, serralysin, serratia peptidase, and serratio peptidase.

The Many Health Benefits of Serrapeptase

Recovery From Injury or Surgery

 The primary use of serrapeptase is in a variety of applications related to recovery and tissue health after an injury. Several human clinical studies have investigated its role in supporting the body's normal response to physical trauma, swelling, and discomfort following minor trauma or surgical and dental procedures. For example, research has examined its use in recovery following dental and other minor surgical procedures. Specifically, in human double-blind clinical trials, serrapeptase has been associated with reductions in swelling and bruising to promote a more rapid recovery from such things as impacted wisdom tooth extraction and other routine dental surgeries.^1,2,4-6

Serrapeptase helps to support recovery by influencing proteins like fibrin involved in normal inflammatory processes and tissue remodeling. Maintaining healthy fibrin balance is important for normal circulation and tissue function at any time, but especially when there is an injury. Because of the activity on fibrin balance, serrapeptase is also recommended in cardiovascular wellness programs.

Supports the Respiratory Tract Lining

A healthy mucus layer is essential for maintaining normal respiratory defenses. Serrapeptase has been investigated for its ability to support normal mucus turnover and clearance. By helping maintain optimal mucus characteristics, serrapeptase may promote respiratory comfort and support the body's natural mechanisms for keeping the airways clear.

 The mucus-supporting effects of serrapeptase may be particularly valuable whenever mucus becomes excessively thick or difficult to clear. Clinical research has shown that serrapeptase may help promote a healthier mucus consistency by reducing excessive thickness and stickiness while maintaining the mucus's natural elasticity. This balance is important because properly functioning mucus serves as one of the body's primary defense mechanisms, helping to trap and remove inhaled particles, irritants, and microorganisms from the respiratory tract.^1,7-9

Supports the Gastrointestinal Lining and Environment 

Serrapeptase has also been investigated for its effects within the gastrointestinal environment. Preliminary laboratory studies suggest that serrapeptase may disrupt components within biofilms—complex communities of microorganisms embedded within a protective matrix that can adhere to intestinal surfaces to disrupt the function of the gastrointestinal lining. These findings have generated interest in the potential role of serrapeptase in supporting the health of the gastrointestinal lining and microbiome.^1,10

Supports Breast Health in Women

Serrapeptase has also been evaluated for its potential to support breast comfort in women. In a placebo-controlled clinical trial published in 1989, seventy women experiencing breast engorgement were randomly assigned to receive either serrapeptase or a placebo for three days. Investigators monitored changes in breast tenderness, swelling, and tissue characteristics throughout the study period. Women receiving serrapeptase experienced greater overall improvement compared with those receiving placebo, with a higher percentage reporting meaningful reductions in discomfort and swelling. The researchers concluded that serrapeptase provided significant support for breast comfort compared with placebo.¹¹

Practical Dosage Recommendations

The dosage of serrapeptase is based on enzyme activity in the form of units of known as serratapeptase units or SPU, typically 40,000 to 125,000 units one to three times daily. Factors effecting dosage level are a person’s size and the level of support a person need.

There are two key additional recommendations that determine maximum benefits. First, serrapeptase should be supplied in a delayed-release (DR) capsule, sometimes also called an enteric-coated capsule or acid-resistant capsule. A DR capsule is designed to resist breakdown in the acidic environment of the stomach and release its contents later in the small intestine. The goal with using a DR capsule with serrapeptase is to prevent it getting destroyed by stomach acid and allowing it to be liberated for absorption in the small intestine. The second key recommendation is to take serrapeptase on an empty stomach either 15 minutes before a meal or 90-minutes after a meal.

When using serrapeptase supplementation before a scheduled procedure because there is limited research evaluating the safety of preoperative use and potential interactions around the time of surgery, a more conservative strategy is to use serrapeptase immediately after the procedure has been completed and recovery has begun.

Safety

Serrapeptase has an excellent safety profile. Human studies and decades of use suggest that it is generally well tolerated when used appropriately. However, because systemic enzymes may influence proteins involved in normal clotting processes, individuals taking anticoagulant or antiplatelet medications should consult their healthcare professional before use.

Final Comments

Systemic enzymes represent one of the most underappreciated categories of dietary supplements. Among them, serrapeptase has generated significant interest because of its broad range of applications involving recovery, circulation, respiratory health, and tissue support. The existing literature and decades of practical use suggest that serrapeptase deserves consideration as part of a comprehensive wellness strategy focused on maintaining healthy function and supporting the body's natural recovery processes.

References:

1. Nair SR, C SD. Serratiopeptidase: An integrated View of Multifaceted Therapeutic Enzyme. Biomolecules. 2022 Oct 13;12(10):1468. 

2. Bhagat S, Agarwal M, Roy V. Serratiopeptidase: a systematic review of the existing evidence. Int J Surg. 2013;11(3):209-217.

3. Hans A. Nieper, G.S. Eagle-Oden, and Arthur D. Alexander. The Curious Man: The Life and Works of Dr. Hans Nieper. Author House, 2010.

4. Tiwari M. The role of serratiopeptidase in the resolution of inflammation. Asian J Pharm Sci. 2017;12(3):209-215.

5. Sivaramakrishnan G, Sridharan K. Role of Serratiopeptidase After Surgical Removal of Impacted Molar: A Systematic Review and Meta-analysis. J Maxillofac Oral Surg. 2018 Jun;17(2):122-128.

6. Esch PM, Gerngross H, Fabian A. Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase-a prospective study Fortschr Med 1989; 107:67-68

7. Majima Y, Inagaki M, Hirata K, et al. The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus. Arch Otorhinolaryngol 1988;244:355-359.

8. Nakamura S, Hashimoto Y, Mikami M, et al. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology 2003;8:316-320.

9. Mazzone A, Catalani M, Costanzo M, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res 1990;18:379-388.

10. Srivastava V, Bandhu S, Mishra S, Chaudhuri TK. Serratiopeptidase exhibits antibiofilm activity through the proteolytic function of N-terminal domain and versatile function of the C-terminal domain. Biochim Biophys Acta Proteins Proteom. 2025 Jan 1;1873(1):141046.

11. Kee WH, Tan SL, Lee V, Salmon YM. The treatment of breast engorgement with Serrapeptase (Danzen); a randomized double-blind controlled trial. Singapore Med J 1989; 30:48-54.